Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1477-7525

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis ; volume:14 ; number:1 ; day:21 ; month:4 ; year:2016 ; pages:1-9 ; date:12.2016
Health and quality of life outcomes ; 14, Heft 1 (21.4.2016), 1-9, 12.2016

Creator: Solem, Caitlyn T.

Contributor: Vera-Llonch, Montserrat
Liu, Sizhu
Botteman, Marc
Castiglione, Brenda
SpringerLink (Online service)

DOI: 10.1186/s12955-016-0465-z

URN: urn:nbn:de:1111-201604222052

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Solem, Caitlyn T.
Vera-Llonch, Montserrat
Liu, Sizhu
Botteman, Marc
Castiglione, Brenda
SpringerLink (Online service)

Other Objects (12)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

Cystic fibrosis

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

Health-related quality of life of Spanish children with cystic fibrosis

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis

Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

Cystic fibrosis

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

Health-related quality of life of Spanish children with cystic fibrosis

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis

Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

Cystic fibrosis

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

Health-related quality of life of Spanish children with cystic fibrosis

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis

Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

Cystic fibrosis

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

Health-related quality of life of Spanish children with cystic fibrosis

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis

Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

Cystic fibrosis

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

Health-related quality of life of Spanish children with cystic fibrosis

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis

Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

Cystic fibrosis

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

Health-related quality of life of Spanish children with cystic fibrosis

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis

Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations

Survival Outcomes in US Medicare Patients with Non-Cystic Fibrosis Bronchiectasis by Rate of Baseline Exacerbations

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study

Related objects

Reset password